TipRanks
Go Ultimate55% OFF

Leslie Chong Insider Profile

4 Followers

Leslie Chong, Managing Director & Chief Executive Officer at Imugene, holds 3.49M shares in Imugene (Ticker: IUGNF), holds 154.90K shares in Chimeric Therapeutics Ltd. (Ticker: AU:CHM). Most recently, Leslie Chong Bought ― shares of Imugene on May 15, 2026 for an estimated value of $61.18K.

Leslie Chong's Trading History

IUGNF
Imugene
May 15, 2026Managing Director & Chief Executive OfficerInformative Buy61.18K$212.89K
CHM
Chimeric Therapeutics Ltd.
Jul 17, 2023FormerInformative Buy5.00KAU$1.70K

You May Also Like

Leslie Chong insider profile FAQ

What is the percentage of profitable transactions made by Leslie Chong?
The percentage of profitable transactions made by Leslie Chong is 30%.
What is the average return per transaction made by Leslie Chong?
The average return per transaction made by Leslie Chong is 107.80%.
What stocks does Leslie Chong hold?
Leslie Chong holds: IUGNF, AU:CHM stocks.
What was Leslie Chong’s latest transaction?
Leslie Chong’s latest transaction was an Informative Buy of $61.18K.
What was Leslie Chong's most profitable transaction?
Leslie Chong’s most profitable transaction was an Informative Buy of IUGNF stock on March 13, 2020. The return on the trade was 787.00%.
What is Leslie Chong's role in Imugene?
Leslie Chong's role in Imugene is Managing Director & Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.